Hippocampus Gene Expression Correlates for MORPH_VCOUNT_2 measured in BXD RI Females & Males obtained using GeneNetwork Hippocampus Consortium M430v2 (Jun06) RMA. The MORPH_VCOUNT_2 measures Morphine TOTAL vertical activity counts under the domain Morphine. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
Hippocampus Gene Expression Correlates for AMCNT165 measured in BXD RI Males obtained using GeneNetwork Hippocampus Consortium M430v2 (Jun06) RMA. The AMCNT165 measures Morphine photocell counts minutes 150-165 under the domain Morphine. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
Neocortex Gene Expression Correlates for AMCNT180 measured in BXD RI Males obtained using GeneNetwork Neocortex ILM6v1.1 (Feb08) RankInv. The AMCNT180 measures Morphine photocell counts minutes 165-180 under the domain Morphine. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
Neocortex Gene Expression Correlates for MDMA_ACT_MDA_1 measured in BXD RI Females & Males obtained using GeneNetwork Neocortex ILM6v1.1 (Feb08) RankInv. The MDMA_ACT_MDA_1 measures Locomotor response of 10 mg/kg MDMA injected on Day 2 under the domain MDMA. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
Neocortex Gene Expression Correlates for MDMA_ACT_MDA_1 measured in BXD RI Females obtained using GeneNetwork Neocortex ILM6v1.1 (Feb08) RankInv. The MDMA_ACT_MDA_1 measures Locomotor response of 10 mg/kg MDMA injected on Day 2 under the domain MDMA. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
QTL for morphine preference on Chr6 at NA (1.89 Mbp , Build 37)
Description:
morphine preference spans 0.00 - 26.89 Mbp (NCBI Build 37) on Chr6. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for METH responses for home cage activity on Chr6 at Met (13.99 Mbp , Build 37)
Description:
METH responses for home cage activity spans 0.00 - 38.99 Mbp (NCBI Build 37) on Chr6. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
Rotarod Baseline Chr# 6 rs6239023(94005991) with right flanking marker rs13459097(84840296) and left marker rs3718735 (101072507). This was mapped in 300 + (b6x129)F2 mice.
QTL associated with bronchial hyperresponsiveness 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (115192871)
Authors:
Ackerman KG, Huang H, Grasemann H, Puma C, Singer JB, Hill AE, Lander E, Nadeau JH, Churchill GA, Drazen JM, Beier DR
QTL associated with cystic fibrosis body weight 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (111954645)
QTL associated with collagen induced arthritis QTL 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (113297319)
QTL associated with collagen induced arthritis QTL 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (75397577)
QTL associated with "early growth rate, maternal effect 2". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (87375892)
QTL associated with ethanol induced locomotor activity 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (87375892)
QTL associated with femoral cross-sectional area 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (88931018)
Authors:
Klein RF, Turner RJ, Skinner LD, Vartanian KA, Serang M, Carlos AS, Shea M, Belknap JK, Orwoll ES
QTL associated with gastritis type A susceptibility locus 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (105955399)
Authors:
Baxter AG, Jordan MA, Silveira PA, Wilson WE, Van Driel IR
QTL associated with immediate cutaneous hypersensitivity QTL. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (107745604)
Authors:
Daser A, Koetz K, Btjer N, Jung M, Rschendorf F, Goltz M, Ellerbrok H, Renz H, Walter J, Paulsen M
GeneWeaver